nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Nucleoside Analog—Azathioprine—systemic scleroderma	0.887	1	CiPCiCtD
Telbivudine—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000203	0.0018	CcSEcCtD
Telbivudine—Dizziness—Pentoxifylline—systemic scleroderma	0.000202	0.0018	CcSEcCtD
Telbivudine—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.000202	0.00179	CcSEcCtD
Telbivudine—Malaise—Mycophenolic acid—systemic scleroderma	0.000202	0.00179	CcSEcCtD
Telbivudine—Malnutrition—Lisinopril—systemic scleroderma	0.000201	0.00179	CcSEcCtD
Telbivudine—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.000201	0.00179	CcSEcCtD
Telbivudine—Fatigue—Captopril—systemic scleroderma	0.0002	0.00178	CcSEcCtD
Telbivudine—Chest pain—Leflunomide—systemic scleroderma	0.000199	0.00177	CcSEcCtD
Telbivudine—Myalgia—Leflunomide—systemic scleroderma	0.000199	0.00177	CcSEcCtD
Telbivudine—Arthralgia—Leflunomide—systemic scleroderma	0.000199	0.00177	CcSEcCtD
Telbivudine—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000199	0.00177	CcSEcCtD
Telbivudine—Sepsis—Methotrexate—systemic scleroderma	0.000198	0.00176	CcSEcCtD
Telbivudine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000198	0.00176	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000198	0.00176	CcSEcCtD
Telbivudine—Dysgeusia—Lisinopril—systemic scleroderma	0.000197	0.00175	CcSEcCtD
Telbivudine—Discomfort—Leflunomide—systemic scleroderma	0.000197	0.00175	CcSEcCtD
Telbivudine—Skin disorder—Azathioprine—systemic scleroderma	0.000197	0.00175	CcSEcCtD
Telbivudine—Cough—Mycophenolic acid—systemic scleroderma	0.000195	0.00173	CcSEcCtD
Telbivudine—Back pain—Lisinopril—systemic scleroderma	0.000195	0.00173	CcSEcCtD
Telbivudine—Vomiting—Pentoxifylline—systemic scleroderma	0.000195	0.00173	CcSEcCtD
Telbivudine—Muscle spasms—Lisinopril—systemic scleroderma	0.000194	0.00172	CcSEcCtD
Telbivudine—Rash—Pentoxifylline—systemic scleroderma	0.000193	0.00171	CcSEcCtD
Telbivudine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000193	0.00171	CcSEcCtD
Telbivudine—Headache—Pentoxifylline—systemic scleroderma	0.000192	0.0017	CcSEcCtD
Telbivudine—Feeling abnormal—Captopril—systemic scleroderma	0.000191	0.0017	CcSEcCtD
Telbivudine—Myalgia—Mycophenolic acid—systemic scleroderma	0.00019	0.00169	CcSEcCtD
Telbivudine—Chest pain—Mycophenolic acid—systemic scleroderma	0.00019	0.00169	CcSEcCtD
Telbivudine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00019	0.00169	CcSEcCtD
Telbivudine—Gastrointestinal pain—Captopril—systemic scleroderma	0.00019	0.00169	CcSEcCtD
Telbivudine—Asthenia—Mometasone—systemic scleroderma	0.00019	0.00168	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000189	0.00168	CcSEcCtD
Telbivudine—Discomfort—Mycophenolic acid—systemic scleroderma	0.000188	0.00167	CcSEcCtD
Telbivudine—Nervous system disorder—Leflunomide—systemic scleroderma	0.000188	0.00167	CcSEcCtD
Telbivudine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000187	0.00166	CcSEcCtD
Telbivudine—Pruritus—Mometasone—systemic scleroderma	0.000187	0.00166	CcSEcCtD
Telbivudine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000187	0.00166	CcSEcCtD
Telbivudine—Skin disorder—Leflunomide—systemic scleroderma	0.000186	0.00165	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000184	0.00164	CcSEcCtD
Telbivudine—Abdominal pain—Captopril—systemic scleroderma	0.000183	0.00163	CcSEcCtD
Telbivudine—Body temperature increased—Captopril—systemic scleroderma	0.000183	0.00163	CcSEcCtD
Telbivudine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000183	0.00162	CcSEcCtD
Telbivudine—Nausea—Pentoxifylline—systemic scleroderma	0.000182	0.00162	CcSEcCtD
Telbivudine—Malaise—Lisinopril—systemic scleroderma	0.000182	0.00161	CcSEcCtD
Telbivudine—Diarrhoea—Mometasone—systemic scleroderma	0.000181	0.00161	CcSEcCtD
Telbivudine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000179	0.00159	CcSEcCtD
Telbivudine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000179	0.00159	CcSEcCtD
Telbivudine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000177	0.00157	CcSEcCtD
Telbivudine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000176	0.00157	CcSEcCtD
Telbivudine—Cough—Lisinopril—systemic scleroderma	0.000176	0.00156	CcSEcCtD
Telbivudine—Muscular weakness—Prednisone—systemic scleroderma	0.000175	0.00156	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000175	0.00156	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000175	0.00155	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000174	0.00155	CcSEcCtD
Telbivudine—Insomnia—Leflunomide—systemic scleroderma	0.000173	0.00154	CcSEcCtD
Telbivudine—Abdominal distension—Prednisone—systemic scleroderma	0.000173	0.00153	CcSEcCtD
Telbivudine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000173	0.00153	CcSEcCtD
Telbivudine—Paraesthesia—Leflunomide—systemic scleroderma	0.000172	0.00153	CcSEcCtD
Telbivudine—Arthralgia—Lisinopril—systemic scleroderma	0.000171	0.00152	CcSEcCtD
Telbivudine—Myalgia—Lisinopril—systemic scleroderma	0.000171	0.00152	CcSEcCtD
Telbivudine—Chest pain—Lisinopril—systemic scleroderma	0.000171	0.00152	CcSEcCtD
Telbivudine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000171	0.00152	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00017	0.00151	CcSEcCtD
Telbivudine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00017	0.00151	CcSEcCtD
Telbivudine—Discomfort—Lisinopril—systemic scleroderma	0.000169	0.0015	CcSEcCtD
Telbivudine—Dyspepsia—Leflunomide—systemic scleroderma	0.000168	0.0015	CcSEcCtD
Telbivudine—Vomiting—Mometasone—systemic scleroderma	0.000168	0.00149	CcSEcCtD
Telbivudine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000167	0.00148	CcSEcCtD
Telbivudine—Rash—Mometasone—systemic scleroderma	0.000167	0.00148	CcSEcCtD
Telbivudine—Asthenia—Captopril—systemic scleroderma	0.000166	0.00148	CcSEcCtD
Telbivudine—Dermatitis—Mometasone—systemic scleroderma	0.000166	0.00148	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000166	0.00148	CcSEcCtD
Telbivudine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000166	0.00147	CcSEcCtD
Telbivudine—Headache—Mometasone—systemic scleroderma	0.000165	0.00147	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000165	0.00147	CcSEcCtD
Telbivudine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000165	0.00147	CcSEcCtD
Telbivudine—Fatigue—Leflunomide—systemic scleroderma	0.000165	0.00146	CcSEcCtD
Telbivudine—Pruritus—Captopril—systemic scleroderma	0.000164	0.00146	CcSEcCtD
Telbivudine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000164	0.00146	CcSEcCtD
Telbivudine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000164	0.00145	CcSEcCtD
Telbivudine—Pain—Leflunomide—systemic scleroderma	0.000164	0.00145	CcSEcCtD
Telbivudine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000161	0.00143	CcSEcCtD
Telbivudine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000161	0.00143	CcSEcCtD
Telbivudine—Neutropenia—Prednisone—systemic scleroderma	0.00016	0.00143	CcSEcCtD
Telbivudine—Body temperature increased—Azathioprine—systemic scleroderma	0.00016	0.00142	CcSEcCtD
Telbivudine—Abdominal pain—Azathioprine—systemic scleroderma	0.00016	0.00142	CcSEcCtD
Telbivudine—Skin disorder—Lisinopril—systemic scleroderma	0.00016	0.00142	CcSEcCtD
Telbivudine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000159	0.00141	CcSEcCtD
Telbivudine—Diarrhoea—Captopril—systemic scleroderma	0.000159	0.00141	CcSEcCtD
Telbivudine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000158	0.0014	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000157	0.0014	CcSEcCtD
Telbivudine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000157	0.0014	CcSEcCtD
Telbivudine—Nausea—Mometasone—systemic scleroderma	0.000157	0.00139	CcSEcCtD
Telbivudine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000156	0.00139	CcSEcCtD
Telbivudine—Pain—Mycophenolic acid—systemic scleroderma	0.000156	0.00139	CcSEcCtD
Telbivudine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000154	0.00137	CcSEcCtD
Telbivudine—Dizziness—Captopril—systemic scleroderma	0.000153	0.00136	CcSEcCtD
Telbivudine—Abdominal pain—Leflunomide—systemic scleroderma	0.000151	0.00134	CcSEcCtD
Telbivudine—Body temperature increased—Leflunomide—systemic scleroderma	0.000151	0.00134	CcSEcCtD
Telbivudine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00015	0.00134	CcSEcCtD
Telbivudine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00015	0.00133	CcSEcCtD
Telbivudine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00015	0.00133	CcSEcCtD
Telbivudine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00015	0.00133	CcSEcCtD
Telbivudine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00015	0.00133	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00015	0.00133	CcSEcCtD
Telbivudine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000149	0.00133	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000149	0.00132	CcSEcCtD
Telbivudine—Insomnia—Lisinopril—systemic scleroderma	0.000149	0.00132	CcSEcCtD
Telbivudine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000148	0.00132	CcSEcCtD
Telbivudine—Paraesthesia—Lisinopril—systemic scleroderma	0.000148	0.00131	CcSEcCtD
Telbivudine—Vomiting—Captopril—systemic scleroderma	0.000148	0.00131	CcSEcCtD
Telbivudine—Rash—Captopril—systemic scleroderma	0.000146	0.0013	CcSEcCtD
Telbivudine—Dermatitis—Captopril—systemic scleroderma	0.000146	0.0013	CcSEcCtD
Telbivudine—Headache—Captopril—systemic scleroderma	0.000145	0.00129	CcSEcCtD
Telbivudine—Dyspepsia—Lisinopril—systemic scleroderma	0.000145	0.00128	CcSEcCtD
Telbivudine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000144	0.00128	CcSEcCtD
Telbivudine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000144	0.00128	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000142	0.00126	CcSEcCtD
Telbivudine—Fatigue—Lisinopril—systemic scleroderma	0.000142	0.00126	CcSEcCtD
Telbivudine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00125	CcSEcCtD
Telbivudine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00125	CcSEcCtD
Telbivudine—Pain—Lisinopril—systemic scleroderma	0.000141	0.00125	CcSEcCtD
Telbivudine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00014	0.00124	CcSEcCtD
Telbivudine—Diarrhoea—Azathioprine—systemic scleroderma	0.000139	0.00123	CcSEcCtD
Telbivudine—Nausea—Captopril—systemic scleroderma	0.000138	0.00122	CcSEcCtD
Telbivudine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000137	0.00122	CcSEcCtD
Telbivudine—Asthenia—Leflunomide—systemic scleroderma	0.000137	0.00122	CcSEcCtD
Telbivudine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000135	0.0012	CcSEcCtD
Telbivudine—Pruritus—Leflunomide—systemic scleroderma	0.000135	0.0012	CcSEcCtD
Telbivudine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000135	0.0012	CcSEcCtD
Telbivudine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000134	0.00119	CcSEcCtD
Telbivudine—Neutropenia—Methotrexate—systemic scleroderma	0.000134	0.00119	CcSEcCtD
Telbivudine—Dizziness—Azathioprine—systemic scleroderma	0.000134	0.00119	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000133	0.00118	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000131	0.00117	CcSEcCtD
Telbivudine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000131	0.00116	CcSEcCtD
Telbivudine—Diarrhoea—Leflunomide—systemic scleroderma	0.000131	0.00116	CcSEcCtD
Telbivudine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00013	0.00116	CcSEcCtD
Telbivudine—Body temperature increased—Lisinopril—systemic scleroderma	0.00013	0.00115	CcSEcCtD
Telbivudine—Abdominal pain—Lisinopril—systemic scleroderma	0.00013	0.00115	CcSEcCtD
Telbivudine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000129	0.00115	CcSEcCtD
Telbivudine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000129	0.00115	CcSEcCtD
Telbivudine—Vomiting—Azathioprine—systemic scleroderma	0.000129	0.00114	CcSEcCtD
Telbivudine—Rash—Azathioprine—systemic scleroderma	0.000128	0.00113	CcSEcCtD
Telbivudine—Dermatitis—Azathioprine—systemic scleroderma	0.000128	0.00113	CcSEcCtD
Telbivudine—Headache—Azathioprine—systemic scleroderma	0.000127	0.00113	CcSEcCtD
Telbivudine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000127	0.00113	CcSEcCtD
Telbivudine—Dizziness—Leflunomide—systemic scleroderma	0.000126	0.00112	CcSEcCtD
Telbivudine—Renal failure—Methotrexate—systemic scleroderma	0.000126	0.00112	CcSEcCtD
Telbivudine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000125	0.00111	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000124	0.0011	CcSEcCtD
Telbivudine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000123	0.00109	CcSEcCtD
Telbivudine—Vomiting—Leflunomide—systemic scleroderma	0.000122	0.00108	CcSEcCtD
Telbivudine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000121	0.00107	CcSEcCtD
Telbivudine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000121	0.00107	CcSEcCtD
Telbivudine—Rash—Leflunomide—systemic scleroderma	0.000121	0.00107	CcSEcCtD
Telbivudine—Dermatitis—Leflunomide—systemic scleroderma	0.00012	0.00107	CcSEcCtD
Telbivudine—Nausea—Azathioprine—systemic scleroderma	0.00012	0.00107	CcSEcCtD
Telbivudine—Headache—Leflunomide—systemic scleroderma	0.00012	0.00106	CcSEcCtD
Telbivudine—Malnutrition—Prednisone—systemic scleroderma	0.00012	0.00106	CcSEcCtD
Telbivudine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000119	0.00105	CcSEcCtD
Telbivudine—Asthenia—Lisinopril—systemic scleroderma	0.000118	0.00105	CcSEcCtD
Telbivudine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000118	0.00105	CcSEcCtD
Telbivudine—Pruritus—Lisinopril—systemic scleroderma	0.000116	0.00103	CcSEcCtD
Telbivudine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000116	0.00103	CcSEcCtD
Telbivudine—Rash—Mycophenolic acid—systemic scleroderma	0.000115	0.00102	CcSEcCtD
Telbivudine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000115	0.00102	CcSEcCtD
Telbivudine—Hepatitis—Methotrexate—systemic scleroderma	0.000115	0.00102	CcSEcCtD
Telbivudine—Headache—Mycophenolic acid—systemic scleroderma	0.000114	0.00102	CcSEcCtD
Telbivudine—Pharyngitis—Methotrexate—systemic scleroderma	0.000114	0.00101	CcSEcCtD
Telbivudine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000114	0.00101	CcSEcCtD
Telbivudine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000114	0.00101	CcSEcCtD
Telbivudine—Nausea—Leflunomide—systemic scleroderma	0.000114	0.00101	CcSEcCtD
Telbivudine—Diarrhoea—Lisinopril—systemic scleroderma	0.000112	0.000999	CcSEcCtD
Telbivudine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000111	0.000985	CcSEcCtD
Telbivudine—Dizziness—Lisinopril—systemic scleroderma	0.000109	0.000965	CcSEcCtD
Telbivudine—Nausea—Mycophenolic acid—systemic scleroderma	0.000108	0.000962	CcSEcCtD
Telbivudine—Malaise—Prednisone—systemic scleroderma	0.000108	0.000958	CcSEcCtD
Telbivudine—Vomiting—Lisinopril—systemic scleroderma	0.000104	0.000928	CcSEcCtD
Telbivudine—Rash—Lisinopril—systemic scleroderma	0.000104	0.00092	CcSEcCtD
Telbivudine—Dermatitis—Lisinopril—systemic scleroderma	0.000104	0.000919	CcSEcCtD
Telbivudine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000103	0.000919	CcSEcCtD
Telbivudine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000918	CcSEcCtD
Telbivudine—Headache—Lisinopril—systemic scleroderma	0.000103	0.000914	CcSEcCtD
Telbivudine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000905	CcSEcCtD
Telbivudine—Myalgia—Prednisone—systemic scleroderma	0.000102	0.000904	CcSEcCtD
Telbivudine—Arthralgia—Prednisone—systemic scleroderma	0.000102	0.000904	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000101	0.000898	CcSEcCtD
Telbivudine—Discomfort—Prednisone—systemic scleroderma	0.000101	0.000893	CcSEcCtD
Telbivudine—Malnutrition—Methotrexate—systemic scleroderma	9.99e-05	0.000888	CcSEcCtD
Telbivudine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	9.85e-05	0.000875	CcSEcCtD
Telbivudine—Dysgeusia—Methotrexate—systemic scleroderma	9.79e-05	0.000869	CcSEcCtD
Telbivudine—Nausea—Lisinopril—systemic scleroderma	9.76e-05	0.000867	CcSEcCtD
Telbivudine—Back pain—Methotrexate—systemic scleroderma	9.67e-05	0.000859	CcSEcCtD
Telbivudine—Nervous system disorder—Prednisone—systemic scleroderma	9.57e-05	0.00085	CcSEcCtD
Telbivudine—Dizziness—Mycophenolate mofetil—systemic scleroderma	9.52e-05	0.000846	CcSEcCtD
Telbivudine—Skin disorder—Prednisone—systemic scleroderma	9.48e-05	0.000842	CcSEcCtD
Telbivudine—Ill-defined disorder—Methotrexate—systemic scleroderma	9.27e-05	0.000824	CcSEcCtD
Telbivudine—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.15e-05	0.000813	CcSEcCtD
Telbivudine—Rash—Mycophenolate mofetil—systemic scleroderma	9.08e-05	0.000806	CcSEcCtD
Telbivudine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.07e-05	0.000806	CcSEcCtD
Telbivudine—Headache—Mycophenolate mofetil—systemic scleroderma	9.02e-05	0.000801	CcSEcCtD
Telbivudine—Malaise—Methotrexate—systemic scleroderma	9.01e-05	0.0008	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	8.89e-05	0.00079	CcSEcCtD
Telbivudine—Insomnia—Prednisone—systemic scleroderma	8.83e-05	0.000784	CcSEcCtD
Telbivudine—Paraesthesia—Prednisone—systemic scleroderma	8.76e-05	0.000778	CcSEcCtD
Telbivudine—Cough—Methotrexate—systemic scleroderma	8.72e-05	0.000775	CcSEcCtD
Telbivudine—Dyspepsia—Prednisone—systemic scleroderma	8.59e-05	0.000763	CcSEcCtD
Telbivudine—Nausea—Mycophenolate mofetil—systemic scleroderma	8.55e-05	0.00076	CcSEcCtD
Telbivudine—Myalgia—Methotrexate—systemic scleroderma	8.51e-05	0.000756	CcSEcCtD
Telbivudine—Arthralgia—Methotrexate—systemic scleroderma	8.51e-05	0.000756	CcSEcCtD
Telbivudine—Chest pain—Methotrexate—systemic scleroderma	8.51e-05	0.000756	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	8.45e-05	0.00075	CcSEcCtD
Telbivudine—Fatigue—Prednisone—systemic scleroderma	8.41e-05	0.000747	CcSEcCtD
Telbivudine—Discomfort—Methotrexate—systemic scleroderma	8.41e-05	0.000747	CcSEcCtD
Telbivudine—Feeling abnormal—Prednisone—systemic scleroderma	8.04e-05	0.000714	CcSEcCtD
Telbivudine—Nervous system disorder—Methotrexate—systemic scleroderma	8e-05	0.00071	CcSEcCtD
Telbivudine—Thrombocytopenia—Methotrexate—systemic scleroderma	7.98e-05	0.000709	CcSEcCtD
Telbivudine—Gastrointestinal pain—Prednisone—systemic scleroderma	7.98e-05	0.000709	CcSEcCtD
Telbivudine—Skin disorder—Methotrexate—systemic scleroderma	7.92e-05	0.000704	CcSEcCtD
Telbivudine—Abdominal pain—Prednisone—systemic scleroderma	7.71e-05	0.000685	CcSEcCtD
Telbivudine—Body temperature increased—Prednisone—systemic scleroderma	7.71e-05	0.000685	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.43e-05	0.00066	CcSEcCtD
Telbivudine—Insomnia—Methotrexate—systemic scleroderma	7.38e-05	0.000655	CcSEcCtD
Telbivudine—Paraesthesia—Methotrexate—systemic scleroderma	7.32e-05	0.000651	CcSEcCtD
Telbivudine—Dyspepsia—Methotrexate—systemic scleroderma	7.18e-05	0.000638	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.04e-05	0.000625	CcSEcCtD
Telbivudine—Fatigue—Methotrexate—systemic scleroderma	7.03e-05	0.000625	CcSEcCtD
Telbivudine—Asthenia—Prednisone—systemic scleroderma	7e-05	0.000622	CcSEcCtD
Telbivudine—Pain—Methotrexate—systemic scleroderma	6.97e-05	0.000619	CcSEcCtD
Telbivudine—Pruritus—Prednisone—systemic scleroderma	6.9e-05	0.000613	CcSEcCtD
Telbivudine—Feeling abnormal—Methotrexate—systemic scleroderma	6.72e-05	0.000597	CcSEcCtD
Telbivudine—Diarrhoea—Prednisone—systemic scleroderma	6.68e-05	0.000593	CcSEcCtD
Telbivudine—Gastrointestinal pain—Methotrexate—systemic scleroderma	6.67e-05	0.000592	CcSEcCtD
Telbivudine—Dizziness—Prednisone—systemic scleroderma	6.45e-05	0.000573	CcSEcCtD
Telbivudine—Abdominal pain—Methotrexate—systemic scleroderma	6.45e-05	0.000573	CcSEcCtD
Telbivudine—Body temperature increased—Methotrexate—systemic scleroderma	6.45e-05	0.000573	CcSEcCtD
Telbivudine—Vomiting—Prednisone—systemic scleroderma	6.2e-05	0.000551	CcSEcCtD
Telbivudine—Rash—Prednisone—systemic scleroderma	6.15e-05	0.000547	CcSEcCtD
Telbivudine—Dermatitis—Prednisone—systemic scleroderma	6.15e-05	0.000546	CcSEcCtD
Telbivudine—Headache—Prednisone—systemic scleroderma	6.11e-05	0.000543	CcSEcCtD
Telbivudine—Asthenia—Methotrexate—systemic scleroderma	5.85e-05	0.00052	CcSEcCtD
Telbivudine—Nausea—Prednisone—systemic scleroderma	5.8e-05	0.000515	CcSEcCtD
Telbivudine—Pruritus—Methotrexate—systemic scleroderma	5.77e-05	0.000513	CcSEcCtD
Telbivudine—Diarrhoea—Methotrexate—systemic scleroderma	5.58e-05	0.000496	CcSEcCtD
Telbivudine—Dizziness—Methotrexate—systemic scleroderma	5.39e-05	0.000479	CcSEcCtD
Telbivudine—Vomiting—Methotrexate—systemic scleroderma	5.19e-05	0.000461	CcSEcCtD
Telbivudine—Rash—Methotrexate—systemic scleroderma	5.14e-05	0.000457	CcSEcCtD
Telbivudine—Dermatitis—Methotrexate—systemic scleroderma	5.14e-05	0.000456	CcSEcCtD
Telbivudine—Headache—Methotrexate—systemic scleroderma	5.11e-05	0.000454	CcSEcCtD
Telbivudine—Nausea—Methotrexate—systemic scleroderma	4.84e-05	0.00043	CcSEcCtD
